Clinical Trial Update: A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating prophylactic Concizumab in patients with severe haemophilia A without inhibitors has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• Concizumab (concizumab)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Haemostasis, Haemophilia A | Phase 2 | Status: COMPLETED | Results posted: 2021-05-10